Company news
Aap Implantate Ag (XETR:AAQ1) news
Aap Implantate Ag news releases on 6ix. Latest, Aug 19, 2026: Aap Implantate AG: Appointment of new board members and change of CEO at aap Implantate AG
Press releases & updates
Aap Implantate AG: Appointment of new board members and change of CEO at aap Implantate AG
August 19, 2026
Aap Implantate AG: Changes in the Management Board
August 19, 2026
Aap confirms growth course at the start of 2026 – revenue slightly above previous year, strong momentum in the USA
May 7, 2026
Aap Implantate AG closes financial year 2025 with earnings improvement and provides outlook for 2026
April 30, 2026
Aap successfully completes MDR certification: All existing products approved according to MDR – market access in the EU and CE-relevant markets secured in the long term
March 18, 2026
Further growth in the fourth quarter leads to annual sales of EUR 12.5 million (+2%); Important milestone achieved in antibacterial implants
February 2, 2026
Aap Implantate AG: Deepblue Holding AG, Subscription as part of a capital increase, private placement
January 7, 2026
Aap Implantate AG: Merval AG, Subscription of shares as part of a private placement in connection with a capital increase with exclusion of subscription rights
January 7, 2026
Aap successfully places a 5.7% capital increase from authorised capital at EUR 1.34, excluding subscription rights
January 6, 2026
Aap Implantate AG: Cash capital increase
December 4, 2025
Aap Implantate AG reports strong growth in Q3/2025: +15%
October 28, 2025
Aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will leave the company at the end of the year
September 19, 2025
Aap Implantate AG closes the first half of the year with sales of € 6.2 million; clinical trial nears positive conclusion
September 16, 2025
Aap successfully completes human clinical trial for antibacterial surface technology
September 9, 2025
Aap Implantate AG: Full admission of all previously unadmitted shares, introduction to stock exchange trading and termination of lock-up agreements
August 1, 2025
Aap Implantate AG publishes final audited consolidated financial statements 2024 - confirmation of strong operational improvement
July 21, 2025
Aap Implantate AG closes financial year 2024 successfully - positive developments despite challenging environment
June 30, 2025
Aap Implantate AG: Company EBITDA for fiscal year 2024 at EUR –0.85 million; postponement of publication of consolidated financial statements
June 27, 2025
Aap makes a stable start to financial year 2025 - growth in the region with the highest sales EMEA region
May 6, 2025
Aap Implantate AG: Postponement of the publication of the annual financial statements and consolidated financial statements for the financial year 2024
April 29, 2025
Announcement of an audit order by BaFin
April 11, 2025